Jérémy B Coquart 1 , Jean-Marie Grosbois 2 , 3 , Cecile Olivier 4 , Frederic Bart 2 , Ingrid Castres 1 , Benoit Wallaert 4
03 June 2016
International Journal of Chronic Obstructive Pulmonary Disease
pulmonary rehabilitation, global management program, severity of airflow obstruction, chronic obstructive pulmonary disease, NMES
This retrospective, observational study of a routine clinical practice reports the feasibility and efficiency of home-based pulmonary rehabilitation (PR), including transcutaneous neuromuscular electrical stimulation (NMES) or usual endurance physical exercise (UEPE), on exercise tolerance, anxiety/depression, and health-related quality of life (HRQoL) in patients with COPD.
Seventy-one patients with COPD participated in home-based PR with NMES (Group NMES [G NMES]), while 117 patients participated in home-based PR with the UEPEs (Group UEPE [G UEPE]). NMES was applied for 30 minutes twice a day, every day. The endurance exercises in G UEPE began with a minimum 10-minute session at least 5 days a week, with the goal being 30–45 minutes per session. Three upper and lower limb muscle strengthening exercises lasting 10–15 minutes were also proposed to both the groups for daily practice. Moreover, PR in both the groups included a weekly 90-minute session based on an educational needs assessment. The sessions comprised endurance physical exercise for G UEPE, NMES for G NMES, resumption of physical daily living activities, therapeutic patient education, and psychosocial support to facilitate health behavior changes. Before and after PR, functional mobility and physical exercise capacity, anxiety, depression, and HRQoL were evaluated at home.
The study revealed that NMES significantly improved functional mobility (−18.8% in GNMES and −20.6% in G UEPE), exercise capacity (+20.8% in G NMES and +21.8% in G UEPE), depression (−15.8% in G NMES and −30.1% in G UEPE), and overall HRQoL (−7.0% in G NMES and −18.5% in G UEPE) in the patients with COPD, regardless of the group (G NMES or G UEPE) or severity of airflow obstruction. Moreover, no significant difference was observed between the groups with respect to these data ( P>0.05).
The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.